The Myeloproliferative Neoplasms Channel on VJHemOnc is an independent medical education platform, supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ASH 2020 | Diagnostic pathology is crucial to guide treatment options
Daniel DeAngelo, MD, PhD, Dana-Farber Cancer Institute, Boston, MA, shares his thoughts on the importance of diagnostic pathology in hematological malignancies. Having a definitive diagnosis based on a pathology review at an academic center is crucial to guide the most appropriate treatment course, and to ultimately get the best outcomes. This interview took place during the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, 2020.
